Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koshi Yamada

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|January 9, 2014
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymesHitoshi Suzuki, Milan Raska, Koshi Yamada, et al.
International Journal of Molecular Sciences|November 9, 2024
Lessons from IgA Nephropathy ModelsToshiki Kano, Hitoshi Suzuki, Yuko Makita, et al.
Biomedicines|December 23, 2022
Mucosal Immune System Dysregulation in the Pathogenesis of IgA NephropathyToshiki Kano, Hitoshi Suzuki, Yuko Makita, et al.
Nephrology (Carlton, Vic.)|April 28, 2026
A Case of Minimal Change Disease Superimposed on Stable Membranous Nephropathy Following the Third Dose of COVID-19 mRNA Vaccine in a Patient With Type 2 DiabetesTakeo Koshida, Tomohito Gohda, Maki Murakoshi, et al.
Kidney International|August 30, 2023
The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathyMingfeng Lee, Hitoshi Suzuki, Kei Ogiwara, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2014
N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathyMilada Stuchlova Horynova, Alena Vrablikova, Tyler J Stewart, et al.
Kidney Diseases (Basel, Switzerland)|June 12, 2020
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA NephropathyKoshi Yamada, Zhi Qiang Huang, Milan Raska, et al.
Kidney International Reports|December 23, 2017
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA NephropathyKoshi Yamada, Zhi-Qiang Huang, Milan Raska, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|January 9, 2014
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymesHitoshi Suzuki, Milan Raska, Koshi Yamada, et al.
International Journal of Molecular Sciences|November 9, 2024
Lessons from IgA Nephropathy ModelsToshiki Kano, Hitoshi Suzuki, Yuko Makita, et al.
Biomedicines|December 23, 2022
Mucosal Immune System Dysregulation in the Pathogenesis of IgA NephropathyToshiki Kano, Hitoshi Suzuki, Yuko Makita, et al.
Nephrology (Carlton, Vic.)|April 28, 2026
A Case of Minimal Change Disease Superimposed on Stable Membranous Nephropathy Following the Third Dose of COVID-19 mRNA Vaccine in a Patient With Type 2 DiabetesTakeo Koshida, Tomohito Gohda, Maki Murakoshi, et al.
Kidney International|August 30, 2023
The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathyMingfeng Lee, Hitoshi Suzuki, Kei Ogiwara, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2014
N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathyMilada Stuchlova Horynova, Alena Vrablikova, Tyler J Stewart, et al.
Kidney Diseases (Basel, Switzerland)|June 12, 2020
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA NephropathyKoshi Yamada, Zhi Qiang Huang, Milan Raska, et al.
Kidney International Reports|December 23, 2017
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA NephropathyKoshi Yamada, Zhi-Qiang Huang, Milan Raska, et al.
Pageof 2